Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 482301 - 482320 out of 495964 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EG01) temsirolimus (adm: P) | TORISEL 25MG/ML INJ 1.8ML,VIAL | 1.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Lymphoma, Mantle-Cell | Pfizer,Inc. |
| USA | (L01EG04) sirolimus | HYFTOR 0.2% GEL,TOP | 10GM | Ex-factory price without vat |
$0-0 |
$0-0 |
Angiofibroma;Tuberous Sclerosis | NobelpharmaAmerica,LLC |
| USA | (L01EH02) neratinib (adm: O) | NERLYNX 40MG TAB | 180 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PumaBiotechnology,Inc. |
| USA | (L01EH02) neratinib (adm: O) | NERLYNX 40MG TAB | 133 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PumaBiotechnology,Inc. |
| USA | (L01EH02) neratinib (adm: O) | NERLYNX 40MG TAB | 180 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PumaBiotechnology,Inc. |
| USA | (L01EH02) neratinib (adm: O) | NERLYNX 40MG TAB | 133 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PumaBiotechnology,Inc. |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 10MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 10MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 15MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 15MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 25MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 25MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 5MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 5MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ02) fedratinib (adm: O) | INREBIC 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Primary Myelofibrosis | Bristol-MyersSquibbCompany |
| USA | (L01EJ02) fedratinib (adm: O) | INREBIC 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Primary Myelofibrosis | Bristol-MyersSquibbCompany |
| USA | (L01EJ03) pacritinib | VONJO 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CTIBiopharmaCorp. |
| USA | (L01EJ03) pacritinib | VONJO 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CTIBiopharmaCorp. |
Pages
